Cargando…

Bugs, drugs, and HIV: the role of the vaginal microbiome in HIV risk and antiretroviral efficacy for HIV prevention

Advances in molecular tools to characterize the microbiome have led to the discovery of unique roles for microbes in human disease. Findings that the female genital microbiome can influence HIV acquisition and prevention emphasize the importance of microbiome analysis in clinical trials that assess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liebenberg, Lenine J. P., Archary, Derseree, Sivro, Aida, Kwon, Douglas S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561602/ https://www.ncbi.nlm.nih.gov/pubmed/28818087 http://dx.doi.org/10.1186/s13073-017-0469-2

Ejemplares similares

Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
por: Zondo, Nomusa M., et al.
Publicado: (2022)

Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women
por: McKinnon, Lyle R., et al.
Publicado: (2018)

Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model
por: Cromarty, Ross, et al.
Publicado: (2021)

Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention
por: Karim, Quarraisha Abdool, et al.
Publicado: (2022)

Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility
por: Cromarty, Ross, et al.
Publicado: (2020)

Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model
por: Cromarty, Ross, et al.
Publicado: (2019)

Preventive HIV Vaccines-Leveraging on Lessons from the Past to Pave the Way Forward
por: Sobia, Parveen, et al.
Publicado: (2021)

Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products
por: Happel, Anna-Ursula, et al.
Publicado: (2022)

Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women
por: Liebenberg, Lenine J. P., et al.
Publicado: (2017)

Semen IgM, IgG1, and IgG3 Differentially Associate With Pro-Inflammatory Cytokines in HIV-Infected Men
por: Pillay, Thevani, et al.
Publicado: (2019)

Increasing HIV prevention and care for injecting drug users
por: Jarlais, Don C Des, et al.
Publicado: (2010)

Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection
por: Rambaran, Santhuri, et al.
Publicado: (2023)

NK cell phenotypic profile during active TB in people living with HIV-evolution during TB treatment and implications for bacterial clearance and disease severity
por: Maseko, Thando Glory, et al.
Publicado: (2023)

HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition
por: Liebenberg, Lenine J. P., et al.
Publicado: (2019)

Monkeypox vaccination—an opportunity for HIV prevention
por: Mussini, Cristina, et al.
Publicado: (2022)

Cultivated Vaginal Microbiomes Alter HIV-1 Infection and Antiretroviral Efficacy in Colonized Epithelial Multilayer Cultures
por: Pyles, Richard B., et al.
Publicado: (2014)

Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage
por: Archary, Derseree, et al.
Publicado: (2015)

Higher mucosal antibody concentrations in women with genital tract inflammation
por: Sobia, Parveen, et al.
Publicado: (2021)

Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection
por: Ntuli, Lungelo, et al.
Publicado: (2022)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice
por: Gallay, Philippe A., et al.
Publicado: (2017)

Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa
por: Pillay, Kimesha, et al.
Publicado: (2021)

Metronidazole Treatment Failure and Persistent BV Lead to Increased Frequencies of Activated T- and Dendritic-Cell Subsets
por: Qulu, Wenkosi Perez, et al.
Publicado: (2023)

Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism
por: Cheu, Ryan K., et al.
Publicado: (2020)

Translating the vaginal microbiome: gaps and challenges
por: Ravel, Jacques, et al.
Publicado: (2016)

Semen: A modulator of female genital tract inflammation and a vector for HIV‐1 transmission
por: Jewanraj, Janine, et al.
Publicado: (2021)

COVID-19 antivirals must not affect HIV drug supply
por: Barber, Melissa, et al.
Publicado: (2022)

Moving towards zero new HIV infections: The importance of combination prevention
por: van Sighem, Ard, et al.
Publicado: (2022)

Risk assessment and the prevention of anal cancer among people living with HIV
por: Burchell, Ann N.
Publicado: (2023)

After Hrs with HIV
por: Amara, Ali, et al.
Publicado: (2003)

Mucoadhesive Vaginal Discs based on Cyclodextrin and Surfactants for the Controlled Release of Antiretroviral Drugs to Prevent the Sexual Transmission of HIV
por: Notario-Pérez, Fernando, et al.
Publicado: (2020)

Rational Development of Liposomal Hydrogels: A Strategy for Topical Vaginal Antiretroviral Drug Delivery in the Context of HIV Prevention
por: Faria, Maria J., et al.
Publicado: (2019)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Take action to mitigate the impact of the COVID-19 pandemic on HIV prevention and control
por: Yan, Xiangyu, et al.
Publicado: (2023)

Managing bacterial sexually transmitted infections (STIs) and preventing HIV/STIs in Europe
por: Bébéar, Cécile, et al.
Publicado: (2023)

HIV Treatment-As-Prevention Research: Authors’ Reply
por: Bärnighausen, Till, et al.
Publicado: (2015)

HIV: from exceptionalism to endgame
por: Sands, Peter
Publicado: (2018)

COVID-19 in people with HIV
por: Xu, Zhe, et al.
Publicado: (2020)

Higher plasma interleukin − 6 levels are associated with lung cavitation in drug-resistant tuberculosis
por: Maseko, Thando Glory, et al.
Publicado: (2023)

Leveraging the advances in HIV for COVID-19
por: McMahon, James H, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kjkc0jb1dosk499v6jtovdjuqn